Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATF4 | P18848 | 18/20 | 0.63 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22612457 | 1.00 | ATF4 (0.63) | ATF4MCHR1LMNA | |
| SCHEMBL22612410 | 0.88 | ATF4 (0.59) | ATF4MCHR1LMNA | |
| SCHEMBL22612408 | 0.88 | ATF4 (0.59) | ATF4MCHR1LMNA | |
| SCHEMBL22612405 | 0.87 | ATF4 (0.56) | ATF4MCHR1LMNA | |
| SCHEMBL22612416 | 0.87 | ATF4 (0.58) | ATF4MCHR1 | |
| SCHEMBL22612418 | 0.87 | ATF4 (0.58) | ATF4MCHR1 | |
| SCHEMBL22612404 | 0.87 | ATF4 (0.56) | ATF4MCHR1LMNA | |
| SCHEMBL22612450 | 0.86 | ATF4 (0.55) | ATF4MCHR1LMNA | |
| SCHEMBL22612448 | 0.86 | ATF4 (0.55) | ATF4MCHR1LMNA | |
| SCHEMBL22612409 | 0.84 | ATF4 (0.59) | ATF4MCHR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112218851-A | Modulators of integrated stress pathways | 卡里科生命科学有限责任公司 | 2021-01-12 | — | — | CN | disclosed |
| US-20200347033-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200347033-A1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | ATF4, ATF1, IRF3 | ATF4 1/4885MCHR1 2082/4885LMNA 3558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.